AOL News has a new home! The Huffington Post.
Click here to visit the new home of Politics Daily!Sen. Ron Wyden, a Democrat from Oregon, announced Thursday that has been diagnosed with early-stage prostate cancer. But in a surprise to many of his colleagues, Wyden, 61, will undergo observation and surgery at Johns Hopkins University Hospital next week at precisely the time Democrats will be trying to lock down votes on the START nuclear arms reduction treaty. ...
Sen. Ron Wyden, a Democrat from Oregon, announced Thursday that has been diagnosed with early-stage prostate cancer. But in a surprise to many of his colleagues, Wyden, 61, will undergo observation and surgery at Johns Hopkins University Hospital next week at precisely the time Democrats will be trying to lock down votes on the START nuclear arms reduction treaty. Wyden's absence could complicate the fate of that measure, since Democrats have a razor-thin margin between victory and defeat and have already factored the senator's support into their vote counts. "I scheduled the surgery ...
(Dec. 9) -- Things are getting hairy in women's facial fashion -- but it's all in the name of charity. That's because this month has been declared "Decembrow" by the feminist-oriented website Feministing, and women are encouraged to grow out their eyebrows to the point where they connect in the middle. Much in the same way that men grow mustaches in "Movember" to raise money and awareness for prostate cancer, Decembrow participants are asked to get pledges and donations for their own pet causes while growing brows that would make hirsute Mexican painter Frida Kahlo proud. Getty ...
(Dec. 1) -- Fellas, quick, take a look. Which is longer: your ring finger or your index finger? A longer index finger gives men a lower risk of prostate cancer, Reuters reports. Men with an index finger longer than their ring finger are one-third less likely to get the disease than men whose finger lengths are the opposite, according to researchers from Britain's Warwick University and the Institute of Cancer Research. "Relative finger length could be used as a simple test for prostate cancer risk, particularly in men aged under 60," Ros Eeles of the Institute of Cancer Research, who helped ...
(Aug. 20) -- Sometimes, out of the darkness comes a burst of light. A New Jersey couple who met at a memorial service honoring the lives of loved ones killed in the 1988 terrorist bombing of Pan Am Flight 103 will be wed a year after the man responsible for the attack was freed from prison and allowed to return to his homeland. Sonia Stratis, 28, and Chris Tedeschi, 33, held the rehearsal dinner for this weekend's wedding on Friday, a year to the day that convicted bomber Abdel Baset al-Megrahi was freed from a Scottish prison and returned to Libya. Al- Megrahi was released for ...
(Aug. 16) -- In the past two months, there've been news accounts of two major diagnostic advances in medicine. One involves a far more efficient HIV detection test that FDA approved in late June. The other is a new prostate cancer test that may reduce the huge number of unnecessary biopsies and surgeries that are currently performed. These breakthroughs appear to have significant life-saving potential. However, surprisingly, the new HIV test isn't all that new -- it's been used in Europe since 2004 and is now the first line of testing in both the United Kingdom and France. As for the prostate ...
(Aug. 6) -- Claiming he was at death's door, convicted Lockerbie bomber Abdel Baset al-Megrahi was freed from prison last summer, eight years into his decades-long prison sentence, to die at home. But he's not dead yet -- and new information suggests that al-Megrahi, who lives back in his native Libya, might not meet the grounds for the "compassionate release" he was granted. What was al-Megrahi's apparent illness? The Lockerbie bomber, 58, is suffering from prostate cancer. He was diagnosed in 2008 and informed the judge responsible for his release that he had fewer than three months to ...
(June 2) -- French researchers have tapped man's best friend to detect those at risk of developing prostate cancer, and it turns out that dogs might do a better job than a much-maligned blood test devised by modern medicine. A team of researchers at Tenon Hospital in Paris trained a Belgian Malinois shepherd, already renowned for its ability to detect bombs, to sniff the urine of men already diagnosed with prostate cancer. The dog was able to correctly identify the urine of a prostate cancer patient, compared with the urine of four healthy individuals. Bizarre as the idea sounds, it's ...
WASHINGTON (April 29) - The Food and Drug Administration has approved a first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease, offering an important alternative to decades-old approaches. Dendreon Corp.'s Provenge vaccine trains the immune system to fight tumors. It's called a "vaccine" even though it treats disease rather than prevents it. Doctors have been trying to develop such a therapy for decades, and Provenge is the first to successfully prolong patient lives. The drug is intended to treat cancer that has spread elsewhere in the body and is ...
(March 31) -- Cancer patients could soon benefit from a new screening device that can pick out and analyze rare tumor cells from standard blood samples, according to a report today in Science Translational Medicine. The device, which is the size of a business card, could be an alternative to surgery, offering a noninvasive way of monitoring whether tumors are spreading to other parts of the body. All it would require is the prick of a needle. "The concept is a blood biopsy," explains Massachusetts General Hospital mechanical engineer Shannon Stott, the study's lead author. "The question is, ...
Follow Politics Daily
POPULAR
News From Our Partners




Top News
More News
More on Aol
Local News
More Blog/Sites
Sites and Services